Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Benefits, Harms, and Costs for Breast Cancer Screening After US Implementation of Digital Mammography
144
Zitationen
18
Autoren
2014
Jahr
Abstract
The transition to digital breast cancer screening in the United States increased total costs for small added health benefits. The value of digital mammography screening among women aged 40 to 49 years depends on women's preferences regarding false positives.
Ähnliche Arbeiten
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 · 111.597 Zit.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 · 87.522 Zit.
Global cancer statistics
2011 · 55.024 Zit.
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
2014 · 29.001 Zit.
Global cancer statistics, 2012
2015 · 27.340 Zit.
Autoren
- Natasha K. Stout
- Sandra J. Lee
- Clyde B. Schechter
- Karla Kerlikowske
- Oğuzhan Alagöz
- Donald A. Berry
- Diana S.M. Buist
- Mücahit Çevik
- Gary B. Chisholm
- Harry J. de Koning
- Hui Huang
- Rebecca A. Hubbard
- Diana L. Miglioretti
- Mark F. Munsell
- Amy Trentham‐Dietz
- Nicolien T. van Ravesteyn
- Anna N.A. Tosteson
- Jeanne S. Mandelblatt
Institutionen
- Harvard Pilgrim Health Care(US)
- Harvard University Press(US)
- Dana-Farber Cancer Institute(US)
- Yeshiva University(US)
- University of California, San Francisco(US)
- University of Wisconsin Carbone Cancer Center(US)
- The University of Texas MD Anderson Cancer Center(US)
- University of Wisconsin–Madison(US)
- Group Health Cooperative(US)
- Erasmus University Rotterdam(NL)
- University of California, Davis(US)
- Dartmouth College(US)
- Dartmouth Hospital(GB)
- Georgetown University(US)